Table 1 Characteristics of 10 patients with lymphangioleiomyomatosis
From: Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
Pat. ID | age* (years) | sirolimus therapy (days) | presence of angiomyolipoma | No. of pregnancies | Smoking history | No. of pneumothoraces |
|---|---|---|---|---|---|---|
1 | 47 | 218 | no | 0 | no | 0 |
2 | 39 | 185 | yes | 1 | no | 1 |
3 | 28 | 325 | no | 0 | no | 2 |
4 | 33 | 758 | no | 1 | no | 1 |
5 | 49 | 749 | no | 3 | no | 1 |
6 | 39 | 817 | yes | 0 | no | 2 |
7 | 48 | 266 | yes | 0 | yes | 0 |
8 | 29 | 191 | no | 2 | yes | 3 |
9 | 51 | 295 | no | 0 | no | 0 |
10 | 58 | 854 | yes | 0 | yes | 0 |